Qu-Shi-Jie-Du Decoction for Prevention of Recurrence and Metastasis in High-Risk Stage II/III Colon Cancer: Study Protocol for a Double-Blind, Randomized, Placebo-Controlled Trial.
Saved in:
| Title: | Qu-Shi-Jie-Du Decoction for Prevention of Recurrence and Metastasis in High-Risk Stage II/III Colon Cancer: Study Protocol for a Double-Blind, Randomized, Placebo-Controlled Trial. |
|---|---|
| Authors: | Chen YD; The Second Clinical College of Guangzhou University of Chinese Medicine, China.; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Guangzhou Key Laboratory of Acupuncture and Medicine Research, China., He ZY; The Second Clinical College of Guangzhou University of Chinese Medicine, China.; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China., Zhao WJ; The Second Clinical College of Guangzhou University of Chinese Medicine, China.; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Guangzhou Key Laboratory of Acupuncture and Medicine Research, China., He YH; The Second Clinical College of Guangzhou University of Chinese Medicine, China.; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Guangzhou Key Laboratory of Acupuncture and Medicine Research, China., Liu YH; The Second Clinical College of Guangzhou University of Chinese Medicine, China.; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China., Zhu YJ; The Second Clinical College of Guangzhou University of Chinese Medicine, China.; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Guangzhou Key Laboratory of Acupuncture and Medicine Research, China., Yu YY; The Second Clinical College of Guangzhou University of Chinese Medicine, China.; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Guangzhou Key Laboratory of Acupuncture and Medicine Research, China., Xiao ZZ; The Second Clinical College of Guangzhou University of Chinese Medicine, China.; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Guangzhou Key Laboratory of Acupuncture and Medicine Research, China., Chang XS; The Second Clinical College of Guangzhou University of Chinese Medicine, China.; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Guangzhou Key Laboratory of Acupuncture and Medicine Research, China., Liu ZB; Shenzhen Zigzag Biotechnology Co., Ltd., China., Zhang HB; The Second Clinical College of Guangzhou University of Chinese Medicine, China.; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Guangzhou Key Laboratory of Acupuncture and Medicine Research, China.; Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou, China.; State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangzhou, China.; State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China. |
| Source: | Integrative cancer therapies [Integr Cancer Ther] 2026 Jan-Dec; Vol. 25, pp. 15347354251396002. Date of Electronic Publication: 2026 Mar 11. |
| Publication Type: | Journal Article; Clinical Trial Protocol |
| Journal Info: | Publisher: Sage Publications Country of Publication: United States NLM ID: 101128834 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-695X (Electronic) Linking ISSN: 15347354 NLM ISO Abbreviation: Integr Cancer Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1552-695X |
|---|---|
| DOI: | 10.1177/15347354251396002 |
